ISU Abxis Co. Ltd (086890) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.088x

Based on the latest financial reports, ISU Abxis Co. Ltd (086890) has a cash flow conversion efficiency ratio of 0.088x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩10.56 Billion ≈ $7.15 Million USD) by net assets (₩120.39 Billion ≈ $81.59 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See ISU Abxis Co. Ltd (086890) net asset quality to measure how much of total assets are equity-financed.

ISU Abxis Co. Ltd - Cash Flow Conversion Efficiency Trend (2014–2024)

This chart illustrates how ISU Abxis Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check 086890 cash to earnings ratio to evaluate the quality of earnings relative to operating cash generation.

ISU Abxis Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ISU Abxis Co. Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
LondonMetric Property Plc LSE:LMP	0.025x
Nebag ag SW:NBEN	0.001x
Aran Research and Development 1982 Ltd TA:ARAN	0.384x
COWELL FASHION Co.Ltd KQ:033290	0.031x
Mgame Corp KQ:058630	-0.004x
Entertainment Network (India) Limited NSE:ENIL	-0.015x
Syntek Semiconductor Co Ltd TWO:5302	0.015x
Chang Type Industrial Co Ltd TW:1541	0.021x

Annual Cash Flow Conversion Efficiency for ISU Abxis Co. Ltd (2014–2024)

The table below shows the annual cash flow conversion efficiency of ISU Abxis Co. Ltd from 2014 to 2024. For the full company profile with market capitalisation and key ratios, see market value of ISU Abxis Co. Ltd.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	₩100.86 Billion ≈ $68.35 Million	₩2.54 Billion ≈ $1.72 Million	0.025x	+172.20%
2023-12-31	₩77.19 Billion ≈ $52.31 Million	₩-2.69 Billion ≈ $-1.82 Million	-0.035x	-459.13%
2022-12-31	₩64.41 Billion ≈ $43.65 Million	₩-401.66 Million ≈ $-272.20K	-0.006x	+92.31%
2021-12-31	₩71.95 Billion ≈ $48.76 Million	₩-5.84 Billion ≈ $-3.96 Million	-0.081x	+58.72%
2020-12-31	₩43.57 Billion ≈ $29.53 Million	₩-8.56 Billion ≈ $-5.80 Million	-0.197x	+17.50%
2019-12-31	₩55.18 Billion ≈ $37.40 Million	₩-13.15 Billion ≈ $-8.91 Million	-0.238x	-6.37%
2018-12-31	₩59.73 Billion ≈ $40.48 Million	₩-13.38 Billion ≈ $-9.07 Million	-0.224x	-101.74%
2017-12-31	₩62.05 Billion ≈ $42.05 Million	₩-6.89 Billion ≈ $-4.67 Million	-0.111x	-86.96%
2016-12-31	₩45.58 Billion ≈ $30.89 Million	₩-2.71 Billion ≈ $-1.83 Million	-0.059x	+28.68%
2015-12-31	₩46.59 Billion ≈ $31.57 Million	₩-3.88 Billion ≈ $-2.63 Million	-0.083x	+87.39%
2014-12-31	₩17.41 Billion ≈ $11.80 Million	₩-11.49 Billion ≈ $-7.79 Million	-0.660x	--

About ISU Abxis Co. Ltd

KQ:086890 Korea Pharmaceuticals

Market Cap

$55.21 Million

₩81.47 Billion KRW

Market Cap Rank

#21481 Global

#1222 in Korea

Share Price

₩3060.00

Change (1 day)

-1.29%

52-Week Range

₩3050.00 - ₩6240.00

All Time High

₩22450.00